3,231 results · 18ms · Sources: EU EUDAMED, US FDA

CANCER ANTIGEN 50

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 50

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 242

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 242

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 242

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 242

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 242

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CANCER ANTIGEN 242

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CALCITONIN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CALCITONIN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CALCITONIN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CALCITONIN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CALCITONIN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

CALCITONIN

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

BNP / PROBNP (INCLUDING OTHER NATRIURIC PEPTIDES)

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

BNP / PROBNP (INCLUDING OTHER NATRIURIC PEPTIDES)

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

BNP / PROBNP (INCLUDING OTHER NATRIURIC PEPTIDES)

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

BNP / PROBNP (INCLUDING OTHER NATRIURIC PEPTIDES)

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

BNP / PROBNP (INCLUDING OTHER NATRIURIC PEPTIDES)

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market

BNP / PROBNP (INCLUDING OTHER NATRIURIC PEPTIDES)

Device
EU IVDD · Eu Ivd General ·Sansure Biotech Inc.·On the market